APA (7th ed.) Citation

Scullion, K. M., MacIntyre, I. M., Sloan-Dennison, S., Clark, B., Fineran, P., Mair, J., . . . Dear, J. W. (2024). Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicological Sciences, 199(2), 203. https://doi.org/10.1093/toxsci/kfae031

Chicago Style (17th ed.) Citation

Scullion, Kathleen M., et al. "Cytokeratin-18 Is a Sensitive Biomarker of Alanine Transaminase Increase in a Placebo-controlled, Randomized, Crossover Trial of Therapeutic Paracetamol Dosing (PATH-BP Biomarker Substudy)." Toxicological Sciences 199, no. 2 (2024): 203. https://doi.org/10.1093/toxsci/kfae031.

MLA (9th ed.) Citation

Scullion, Kathleen M., et al. "Cytokeratin-18 Is a Sensitive Biomarker of Alanine Transaminase Increase in a Placebo-controlled, Randomized, Crossover Trial of Therapeutic Paracetamol Dosing (PATH-BP Biomarker Substudy)." Toxicological Sciences, vol. 199, no. 2, 2024, p. 203, https://doi.org/10.1093/toxsci/kfae031.